The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Coulie Bernard since 2020.
This trader's CIK number is 1808895.
At the time of last reporting, Coulie Bernard was the President and CEO of Pliant Therapeutics, Inc.. (stock ticker symbol PLRX).
Also see all insider trading activities at Pliant Therapeutics, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2025 | PLRX | 0 | $0 | 52,419 | $587,145 | 0 | $0 |
| 2024 | PLRX | 0 | $0 | 64,431 | $890,659 | 0 | $0 |
| 2023 | PLRX | 0 | $0 | 375,489 | $10,261,856 | 230,000 | $695,750 |
| 2022 | PLRX | 0 | $0 | 61,710 | $1,272,222 | 27,498 | $57,195 |
| 2021 | PLRX | 0 | $0 | 21,500 | $685,545 | 6,000 | $12,480 |
| 2020 | PLRX | 0 | $0 | 3,500 | $96,558 | 48,840 | $202,686 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-01-17 | PLRX | Sale | 52,419 | 11.20 | 587,145 |
| 2024-07-10 | PLRX | Sale | 38,710 | 11.56 | 447,487 |
| 2024-01-17 | PLRX | Sale | 25,721 | 17.23 | 443,172 |
| 2023-07-17 | PLRX | Sale | 70,150 | 18.01 | 1,263,331 |
| 2023-03-30 | PLRX | Sale | 35,339 | 26.52 | 937,225 |
| 2023-02-03 | PLRX | Sale | 15,000 | 33.72 | 505,800 |
| 2023-02-02 | PLRX | Sale | 15,000 | 34.54 | 518,130 |
| 2023-02-03 | PLRX | Option Ex | 15,000 | 6.22 | 93,300 |
| 2023-02-02 | PLRX | Option Ex | 15,000 | 6.22 | 93,300 |
| 2023-01-31 | PLRX | Sale | 15,000 | 34.92 | 523,755 |
| 2023-01-30 | PLRX | Sale | 15,000 | 34.32 | 514,755 |
| 2023-02-01 | PLRX | Sale | 15,000 | 34.83 | 522,390 |
| 2023-01-31 | PLRX | Option Ex | 15,000 | 4.15 | 62,250 |
| 2023-01-30 | PLRX | Option Ex | 15,000 | 2.08 | 31,200 |
| 2023-02-01 | PLRX | Option Ex | 15,000 | 6.22 | 93,300 |
| 2023-01-27 | PLRX | Sale | 25,000 | 35.80 | 895,025 |
| 2023-01-26 | PLRX | Sale | 30,000 | 35.19 | 1,055,790 |
| 2023-01-27 | PLRX | Option Ex | 15,000 | 2.08 | 31,200 |
| 2023-01-26 | PLRX | Option Ex | 15,000 | 2.08 | 31,200 |
| 2023-01-23 | PLRX | Sale | 30,000 | 34.55 | 1,036,380 |
| 2023-01-25 | PLRX | Option Ex | 15,000 | 2.08 | 31,200 |
| 2023-01-24 | PLRX | Sale | 15,000 | 30.89 | 463,395 |
| 2023-01-25 | PLRX | Sale | 15,000 | 32.84 | 492,675 |
| 2023-01-23 | PLRX | Option Ex | 15,000 | 2.08 | 31,200 |
| 2023-01-24 | PLRX | Option Ex | 15,000 | 2.08 | 31,200 |
| 2023-01-06 | PLRX | Option Ex | 15,000 | 2.08 | 31,200 |
| 2023-01-06 | PLRX | Sale | 15,000 | 19.04 | 285,585 |
| 2023-01-09 | PLRX | Option Ex | 5,000 | 2.08 | 10,400 |
| 2023-01-09 | PLRX | Sale | 5,000 | 19.17 | 95,830 |
| 2023-01-04 | PLRX | Sale | 15,000 | 19.06 | 285,945 |
| 2023-01-03 | PLRX | Sale | 15,000 | 19.33 | 289,950 |
| 2023-01-04 | PLRX | Option Ex | 15,000 | 2.08 | 31,200 |
| 2023-01-03 | PLRX | Option Ex | 15,000 | 2.08 | 31,200 |
| 2023-01-04 | PLRX | Sale | 15,000 | 19.06 | 285,945 |
| 2023-01-03 | PLRX | Sale | 15,000 | 19.33 | 289,950 |
| 2023-01-04 | PLRX | Option Ex | 15,000 | 2.08 | 31,200 |
| 2023-01-03 | PLRX | Option Ex | 15,000 | 2.08 | 31,200 |
| 2022-12-20 | PLRX | Sale | 34,212 | 19.10 | 653,517 |
| 2022-07-12 | PLRX | Sale | 12,498 | 22.50 | 281,205 |
| 2022-07-11 | PLRX | Sale | 15,000 | 22.50 | 337,500 |
| 2022-07-12 | PLRX | Option Ex | 12,498 | 2.08 | 25,995 |
| 2022-07-11 | PLRX | Option Ex | 15,000 | 2.08 | 31,200 |
| 2021-06-14 | PLRX | Sale | 4,000 | 33.34 | 133,344 |
| 2021-05-14 | PLRX | Sale | 3,500 | 28.90 | 101,157 |
| 2021-04-14 | PLRX | Sale | 3,500 | 30.33 | 106,162 |
| 2021-04-13 | PLRX | Option Ex | 6,000 | 2.08 | 12,480 |
| 2021-03-15 | PLRX | Sale | 3,500 | 38.82 | 135,873 |
| 2021-02-16 | PLRX | Sale | 3,500 | 33.01 | 115,542 |
| 2021-01-14 | PLRX | Sale | 3,500 | 26.70 | 93,467 |
| 2020-12-14 | PLRX | Sale | 3,500 | 27.59 | 96,558 |
| 2020-04-30 | PLRX | Option Ex | 48,840 | 4.15 | 202,686 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Coulie Bernard (President and CEO of Pliant Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.